A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation

This open-label non-inferiority study assessed efficacy of a common outpatient medical abortion regimen among people with pregnancies 64-70 days and 71-77 days of gestation.Study DesignWe defined non-inferiority by a 6% margin of method success. People with intrauterine pregnancies 64-77 days ’ gestational age by abdominal ultrasound seeking medical abortion at one of eight clinics and met eligibility criteria were offered participation. Consenting participants took mifepristone 200 mg followed 24-48 hours later by misoprostol 800 mcg buccally, and returned after one week for provider evaluation and abdominal ultrasound to determine abortion status.

Source: Contraception - January 30, 2020 Category: OBGYN Authors: Ilana G. Dzuba, Erica Chong, Curtiss Hannum, E. Steve Lichtenberg, Elba Margarita Lugo Hern ández, Nguyen thi Nhu Ngoc, Ashlesha Patel, Gulnara Rzayeva, Patricio Sanhueza Smith, George Tsertsvadze, Beverly Winikoff Tags: Original Research Article Source Type: research